bmj;377/apr27_11/o1035/FAF1faAfrica’s vast and difficult terrain makes the delivery of healthcare to its many remote communities challenging. But thanks […]
Month: April 2022
AbstractObjectiveTo describe the development and validation of a novel patient reported outcome measure for symptom burden from long […]
When it comes to managing the adoption of new technology, change always takes time. The question is how […]
Brophy emphasises the dangers of making decisions based on a single prematurely terminated trial.1 The molnupiravir trials have […]
GARDP neonatal sepsis study was carried out in 19 hospitals across four continents
MMM is a global campaign which raises awareness of high blood pressure and its long-term implications
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis […]
Can the treatment of seriously ill children with rare diseases be improved by rapid genetic diagnosis? This question […]
The British company APIS Assay Technologies Ltd has acquired the University of Bonn’s spin-off project Clickmer Systems, which […]
How many children have been affected?The World Health Organization has so far reported 169 cases of acute hepatitis […]